Zogenix files for $90 million IPO

September 7, 2010 by MassDevice staff

Zogenix Inc. files for a $90 million initial public offering to fund the development of pain medications and a needle-free injector.

Zogenix logo

Zogenix Inc. is attempting to raise $90 million through an initial public offering.

The San Diego-based company said it plans utilize the new funds to help commercialize its Sumavel DosePro drug-device combination and the clinical advancement of its ZX002 drug in a Securities & Exchange Commission filing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.